RPHM - Reneo Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Reneo Pharmaceuticals's activity chart (see below) currently has 15 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.36% with an average time for these price targets to be met of 169.91 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 14-May-2024. First documented stock forecast 04-May-2021.

Best performing analysts who are covering RPHM - Reneo Pharmaceuticals:

Eun Yang Yasmeen Rahimi Mitchell Kapoor Gobind Singh Joseph Schwartz Brian Skorney

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Mitchell Kapoor (HC WAINWRIGHT)

Hold Since 14-May-2024

$30

Please subscribe to see extended stock data

Joseph Schwartz (LEERINK)

Hold Since 15-Dec-2023

$15

Please subscribe to see extended stock data

Eun Yang (JEFFERIES)

$1.8

$-0.02 (-1.10%)

$24

Please subscribe to see extended stock data

Yasmeen Rahimi (PIPER SANDLER)

Buy Since 04-May-2021

$2.18 (119.78%)

Please subscribe to see extended stock data

Gobind Singh

Buy Since 19-Sep-2022

$30

$28.18 (1548.35%)

$30

Please subscribe to see extended stock data

Show more analysts

Load Price Targets and Ratings Chart

Please expand the browser size to see the chart

What is RPHM (Reneo Pharmaceuticals) average time for price targets to be met?

On average it took 169.91 days on average for the stock forecasts to be realized with a an average price target met ratio 86.36

Which analyst has the current highest performing score on RPHM (Reneo Pharmaceuticals) with a proven track record?

EUN YANG

Which analyst has the most public recommendations on RPHM (Reneo Pharmaceuticals)?

Eun Yang has 2 price targets and 1 ratings on RPHM

Which analyst is the currently most bullish on RPHM (Reneo Pharmaceuticals)?

Matthew Kaplan with highest potential upside - $43.18

Which analyst is the currently most reserved on RPHM (Reneo Pharmaceuticals)?

Eun Yang with lowest potential downside - -$0.02